Amanda F Cashen
Washington University School of Medicine
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Amanda F Cashen as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 09:27 UTC. Open this list on ClinicalTrials.gov
- Ph2NCT06687772 · CNS-Relapse Prevention in High-Risk Diffuse Large B-cell Lymphoma With Thiotepa-based Autologous Stem Cell TransplantWashington University School of Medicine · recruiting · Diffuse Large B Cell Lymphoma · principal investigator
- Ph1/Ph2NCT00733824 · Intravenous AMD3100 for Collection of Autologous Peripheral Blood Stem Cells in Patients With LymphomaWashington University School of Medicine · completed · Lymphoma, Non-Hodgkin, Hodgkin Disease · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 09:27 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
- Clinical Protocol and Data ManagementP30CA091842 · NCI · WASHINGTON UNIVERSITY · fiscal years 2026 · $832,810 awarded in 2026Same name and institution; not confirmed by an ID
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-12 09:27 UTC. The ranking covers the 200 most relevant of 42 PubMed records, and a shared surname and initials can bring in a namesake. All 42 on PubMed
- TP53 and Decitabine in Acute Myeloid Leukemia and Myelodysplastic Syndromes.N Engl J Med · 2016724 citationsRCR 21.4
- Ibrutinib-Rituximab or Chemoimmunotherapy for Chronic Lymphocytic Leukemia.N Engl J Med · 2019645 citationsRCR 24.0
- Multicenter, phase II study of decitabine for the first-line treatment of older patients with acute myeloid leukemia.J Clin Oncol · 2010387 citationsRCR 8.2
- 348 citationsRCR 11.0
- 339 citationsRCR 8.6
- 299 citationsRCR 9.2
- 221 citationsRCR 15.9
- Maintenance Therapy with Decitabine after Allogeneic Stem Cell Transplantation for Acute Myelogenous Leukemia and Myelodysplastic Syndrome.Biol Blood Marrow Transplant · 2015153 citationsRCR 4.9
- A phase 2 multicenter study of lenalidomide in relapsed or refractory classical Hodgkin lymphoma.Blood · 2011150 citationsRCR 3.5
- 140 citationsRCR 9.0